SCHEMBL7515770

SCHEMBL7515770

CC(C)Cc1ccc(NC(=O)NN)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
EPHX1 P07099 2/20 0.46
EPHX2 P34913 2/20 0.46
KDM4E B2RXH2 1/20 0.45
TSHR P16473 1/20 0.45
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
MEN1 O00255 2/20 0.43
NPC1 O15118 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 1/20 0.43
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7523145 0.85 EPHX2 (0.51) LMNAEPHX1EPHX2TSHRGAA
SCHEMBL7528869 0.81 MEN1 (0.48) LMNAEPHX1EPHX2TSHRGAA
SCHEMBL7519932 0.79 EPHX2 (0.49) LMNAEPHX1EPHX2GAASMN1; SMN2
SCHEMBL9202790 0.76 EPHX1 (0.78) LMNAEPHX1EPHX2KDM4EGAA
SCHEMBL7515777 0.76 EPHX1 (0.45) LMNAEPHX1EPHX2KDM4ETSHR
SCHEMBL7554903 0.76 RAB9A (0.42) LMNAEPHX1EPHX2KDM4ETSHR
SCHEMBL7528507 0.75 SMN1; SMN2 (0.67) EPHX1EPHX2KDM4ETSHRGAA
Hydrochloric Acid SCHEMBL5119147 0.75 EPHX1 (0.75) LMNAEPHX1EPHX2KDM4EGAA
SCHEMBL27985529 0.73 EPHX1 (0.61) LMNAEPHX1EPHX2GAASMN1; SMN2
SCHEMBL7523868 0.73 LMNA (0.38) LMNAEPHX1EPHX2KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed